Hainan Shuangcheng Pharmaceut (002693) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.083x

Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.67 Million ≈ $4.93 Million USD) by net assets (CN¥404.35 Million ≈ $59.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hainan Shuangcheng Pharmaceut - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Hainan Shuangcheng Pharmaceut's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002693 current and long-term liabilities for a breakdown of total debt and financial obligations.

Hainan Shuangcheng Pharmaceut Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Rutong Petro-Machinery
SHG:603036
0.044x
Electra Co Pr
TA:ECP
0.097x
Jana Small Finance Bank
NSE:JSFB
-0.220x
Zhejiang Tiantai Xianghe Industrial Co Ltd
SHG:603500
0.009x
Anhui Xinbo Aluminum Co Ltd
SHE:003038
-0.140x
Nanjing Railway New Technology Co.Ltd.
SHE:301016
0.031x
Hefei Gocom Information Technology Co Ltd
SHG:688367
0.036x
Beijing Haohan Data Technology Co. Ltd. A
SHG:688292
N/A

Annual Cash Flow Conversion Efficiency for Hainan Shuangcheng Pharmaceut (2009–2024)

The table below shows the annual cash flow conversion efficiency of Hainan Shuangcheng Pharmaceut from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 002693 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥411.61 Million
≈ $60.23 Million
CN¥-40.83 Million
≈ $-5.97 Million
-0.099x -541.12%
2023-12-31 CN¥517.65 Million
≈ $75.75 Million
CN¥11.64 Million
≈ $1.70 Million
0.022x -48.20%
2022-12-31 CN¥580.94 Million
≈ $85.01 Million
CN¥25.22 Million
≈ $3.69 Million
0.043x +4.45%
2021-12-31 CN¥566.75 Million
≈ $82.93 Million
CN¥23.55 Million
≈ $3.45 Million
0.042x +336.77%
2020-12-31 CN¥598.31 Million
≈ $87.55 Million
CN¥-10.50 Million
≈ $-1.54 Million
-0.018x -117.88%
2019-12-31 CN¥678.26 Million
≈ $99.25 Million
CN¥66.58 Million
≈ $9.74 Million
0.098x +40.36%
2018-12-31 CN¥669.69 Million
≈ $98.00 Million
CN¥46.84 Million
≈ $6.85 Million
0.070x +336.39%
2017-12-31 CN¥761.71 Million
≈ $111.46 Million
CN¥-22.54 Million
≈ $-3.30 Million
-0.030x -142.35%
2016-12-31 CN¥553.13 Million
≈ $80.94 Million
CN¥38.65 Million
≈ $5.66 Million
0.070x +40.17%
2015-12-31 CN¥927.61 Million
≈ $135.74 Million
CN¥46.24 Million
≈ $6.77 Million
0.050x -12.67%
2014-12-31 CN¥893.55 Million
≈ $130.75 Million
CN¥51.00 Million
≈ $7.46 Million
0.057x -11.95%
2013-12-31 CN¥870.62 Million
≈ $127.40 Million
CN¥56.43 Million
≈ $8.26 Million
0.065x -31.65%
2012-12-31 CN¥845.85 Million
≈ $123.77 Million
CN¥80.22 Million
≈ $11.74 Million
0.095x -67.23%
2011-12-31 CN¥228.23 Million
≈ $33.40 Million
CN¥66.05 Million
≈ $9.67 Million
0.289x -17.45%
2010-12-31 CN¥157.82 Million
≈ $23.09 Million
CN¥55.33 Million
≈ $8.10 Million
0.351x -38.27%
2009-12-31 CN¥77.95 Million
≈ $11.41 Million
CN¥44.27 Million
≈ $6.48 Million
0.568x --

About Hainan Shuangcheng Pharmaceut

SHE:002693 China Drug Manufacturers - Specialty & Generic
Market Cap
$520.65 Million
CN¥3.56 Billion CNY
Market Cap Rank
#12331 Global
#3822 in China
Share Price
CN¥8.58
Change (1 day)
-0.35%
52-Week Range
CN¥6.52 - CN¥9.16
All Time High
CN¥38.37
About

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmace… Read more